Adicet Bio Inc (NASDAQ:ACET) shares, rose in value on Wednesday, June 18, with the stock price down by -0.49% to the previous day’s close as strong demand from buyers drove the stock to $0.67.
Actively observing the price movement in the last trading, the stock closed the session at $0.67, falling within a range of $0.6652 and $0.7001. The value of beta (5-year monthly) was 1.657. Referring to stock’s 52-week performance, its high was $1.70, and the low was $0.45. On the whole, ACET has fluctuated by -5.20% over the past month.
With the market capitalization of Adicet Bio Inc currently standing at about $55.34 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-06.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ACET’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ACET currently trading nearly -8.92% and 1.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.17, while the 7-day volatility ratio is showing 2.45% which for the 30-day chart, stands at 4.64%. Furthermore, Adicet Bio Inc (ACET)’s beta value is 1.68, and its average true range (ATR) is 0.06.
A comparison of Adicet Bio Inc (ACET) with its peers suggests the former has fared considerably weaker in the market. ACET showed an intraday change of -0.49% in last session, and over the past year, it shrunk by -50.44%%.
Data on historical trading for Adicet Bio Inc (NASDAQ:ACET) indicates that the trading volumes over the past 10 days have averaged 0.34 and over the past 3 months, they’ve averaged 534.90K. According to company’s latest data on outstanding shares, there are 82.71 million shares outstanding.
Nearly 20.99% of Adicet Bio Inc’s shares belong to company insiders and institutional investors own 49.04% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.13 million shares as on 2025-05-30, resulting in a short ratio of 4.36. According to the data, the short interest in Adicet Bio Inc (ACET) stood at 506.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 2.04 million. The stock has fallen by -30.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ACET stock heading into the next quarter.
